The latest closing stock price for Achilles Therapeutics as of November 08, 2024 is 1.05.
An investor who bought $1,000 worth of Achilles Therapeutics stock at the IPO in 2021 would have $-937 today, roughly -1 times their original investment - a -49.81% compound annual growth rate over 4 years.
The all-time high Achilles Therapeutics stock closing price was 17.86 on April 06, 2021.
The Achilles Therapeutics 52-week high stock price is 1.76, which is 67.6% above the current share price.
The Achilles Therapeutics 52-week low stock price is 0.63, which is 40% below the current share price.
The average Achilles Therapeutics stock price for the last 52 weeks is 0.92.
An investor who bought $1,000 worth of Achilles Therapeutics stock at the IPO in 2021 would have $-937 today, roughly -1 times their original investment - a -49.81% compound annual growth rate over 4 years.
The all-time high Achilles Therapeutics stock closing price was 17.86 on April 06, 2021.
The Achilles Therapeutics 52-week high stock price is 1.76, which is 67.6% above the current share price.
The Achilles Therapeutics 52-week low stock price is 0.63, which is 40% below the current share price.
The average Achilles Therapeutics stock price for the last 52 weeks is 0.92.